XBiotech Inc (XBIT)

NASDAQ
13.40
+0.41(+3.16%)
After Hours
13.40
+0.01(+0.07%)
- Real-time Data
  • Volume:
    57,521
  • Bid/Ask:
    12.80/16.50
  • Day's Range:
    13.04 - 13.53

XBIT Overview

Prev. Close
12.99
Day's Range
13.04-13.53
Revenue
25.2M
Open
13.04
52 wk Range
12.2-20.75
EPS
-0.41
Volume
57,521
Market Cap
407.07M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
57,437
P/E Ratio
-
Beta
1.5
1-Year Change
-27.84%
Shares Outstanding
30,378,209
Next Earnings Date
Nov 11, 2021
What is your sentiment on XBiotech Inc?
or
Market is currently closed. Voting is open during market hours.

XBiotech Inc News

XBiotech Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyBuySellSell
Technical IndicatorsSellStrong BuyStrong BuyBuyStrong Sell
SummaryNeutralStrong BuyStrong BuyNeutralStrong Sell

XBiotech Inc Company Profile

XBiotech Inc Company Profile

Employees
94

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).

Read More
  • 🚀🚀this is the beginning
    1
    • bullish
      1
      • Buy this stock its going up
        2
        • Cancer treatment misdiagnosed by 3rd party source!?! Back in action on its way for fda approval!?! Stocks expected to jump additional $10+ per share within days! Whatttttt
          1
          • Will xbit see 5 again anytime soon?
            0
            • Any opinions on where you think this stock is heading would be greatly appreciated. I have my own opinions based off facts, but as we all know nothings set in stone. I'd love to hear from someone about xbit and where it's heading in your opinion.
              0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.